Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
48.00    -0.50 (-1.03%)
Bid:
47.00
Ask:
49.00
Spread: 2.00 (4.255%)
Market Cap: £7.31m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

Total Voting Rights

31 May 2023 17:00

RNS Number : 1669B
Transense Technologies PLC
31 May 2023
 

31 May 2023

 

Transense Technologies plc

 ("Transense" or the "Company")

 

Total voting rights

 

Transense Technologies plc, the provider of specialist sensor systems, announces that the issued share capital of the Company at the date of this announcement comprises 16,437,740 ordinary shares of 10 pence ("Ordinary Shares"). The Company holds 764,027 Ordinary Shares in treasury and therefore, the total number of voting rights in the Company is 15,673,713.

 

The figure of 15,673,713 should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (CFO)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter / George Payne (Corporate Finance)

Tony Quirke/Jos Pinnington (Sales and Corporate Broking)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper / Nick Rome

Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com

Notes to Editors:

 

 

Notes to Editors:

Transense is headquartered in Oxfordshire, UK and its shares are traded on AIM, a market operated by the London Stock Exchange (AIM: TRT). The Company develops and supplies wireless sensor technology and systems, and currently has three business segments:

SAW - patent protected Surface Acoustic Wave sensor technology that provides real time measurement of torque, temperature, pressure and strain, and is used to improve efficiency, performance, safety and sustainability of propulsion systems and machinery. Current focus is the development of a pipeline of high calibre customers and collaborative partnerships for a variety of applications in electric drives, aerospace, industrial machinery (including off-highway and robotics) and high performance automotive sectors.

Translogik - smart, connected commercial vehicle tyre inspection equipment, used by vehicle fleets to more easily gather and maintain accurate tyre safety and condition data; and,

iTrack - a tyremonitoring system for off-highway vehicles, licensed exclusively to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal expiring in 2030.

For further information please contact transense@walbrookpr.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRFZGFKRMKGFZG
Date   Source Headline
26th Apr 20191:42 pmRNSHolding(s) in Company
4th Apr 201910:31 amRNSHolding(s) in Company
1st Apr 20193:02 pmRNSResult of General Meeting
22nd Mar 201910:30 amRNSHolding(s) in Company
20th Mar 201910:02 amRNSHolding(s) in Company
15th Mar 20199:33 amRNSNotice of GM and Posting of Circular
14th Mar 20193:30 pmRNSEIS Advance Assurance and Total Voting Rights
13th Mar 20193:35 pmRNSPlacing & General Meeting
13th Mar 20193:35 pmRNSInterim Results
22nd Feb 20198:36 amRNSHolding(s) in Company
20th Feb 20198:30 amRNSiTrack Contract Win
18th Feb 20197:00 amRNSSignificant iTrack Order
4th Feb 20197:00 amRNSGE Aviation Contract Win
21st Dec 20181:22 pmRNSResult of AGM
21st Dec 20187:00 amRNSAGM Statement
21st Nov 20187:00 amRNSNotice of AGM
12th Nov 20187:00 amRNSTranslogik iTrack Contract Win in new Territory
9th Oct 20187:00 amRNSFinal Results
26th Sep 20187:00 amRNSNotice of Results
23rd Aug 20182:44 pmRNSHolding(s) in Company
1st Aug 20187:00 amRNSTrading Update
25th Jun 20188:29 amRNSHolding(s) in Company
21st Jun 20182:33 pmRNSResult of General Meeting
31st May 20187:00 amRNSPlacing and Notice of General Meeting
8th May 20187:00 amRNSNew Translogik iTrack Contract Win
2nd Mar 201812:26 pmRNSStatement re joint broker
7th Feb 20187:00 amRNSInterim Results
5th Feb 20189:56 amRNSHolding(s) in Company
21st Dec 20171:09 pmRNSResult of AGM
21st Dec 20177:00 amRNSAGM Statement
18th Dec 201711:18 amRNSIssue of Equity
27th Nov 20179:29 amRNSContract Win
14th Nov 20177:00 amRNSNotice of AGM
26th Sep 20177:00 amRNSFinal Results
5th Sep 20177:00 amRNSNotice of Results
5th Sep 20177:00 amRNSInvestor Event
7th Aug 20177:00 amRNSNew iTrack Contract Win with BHP in Australia
31st Jul 20177:00 amRNSTrading Update
27th Jun 20177:00 amRNSAward of options
26th Jun 20177:00 amRNSGlencore - Further Contract Win
6th Jun 20177:00 amRNSDirector/PDMR Shareholding
5th Jun 20177:00 amRNSGlencore - Further Contract Win
4th Apr 20175:20 pmRNSHolding(s) in Company
29th Mar 20177:01 amRNSInterim results
29th Mar 20177:00 amRNSFurther Payment from General Electric
1st Mar 20177:00 amRNSInvestor Event
28th Feb 20171:54 pmRNSNotice of Results
27th Jan 20177:00 amRNSIssue of Equity
22nd Dec 20168:19 amRNSCapital Reduction
23rd Nov 20163:45 pmRNSResult of AGM & Share Consolidation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.